You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Drugs Containing Excipient (Inactive Ingredient) GLYCERYL PALMITOSTEARATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing GLYCERYL PALMITOSTEARATE excipient, and estimated key patent expiration / generic entry dates

Market Dynamics and Financial Trajectory of Glycerl Palmitostearate

Last updated: February 21, 2026

What is Glycerl Palmitostearate?

Glycerl Palmitostearate (also listed as Glyceryl Palmitostearate or Glycerol Esters of Palmitostearic Acid) is a lipid-based excipient used as an emulsifier, stabilizer, and thickening agent in pharmaceuticals, cosmetics, and food products. It enhances product stability, improves texture, and extends shelf life. As a functionally versatile excipient, its market utilization correlates with regulatory acceptance and demand in relevant industries.

Market Size and Growth Trends

Global Market Valuation

The global market for glycerol esters, including Glycerl Palmitostearate, was valued at approximately $250 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2028, reaching roughly $330 million by 2028. The growth is driven by increasing demand for emollients and stabilizers in pharmaceuticals and cosmetics.

Year Market Value (USD million) CAGR (%)
2022 250
2023 263 5.2
2024 277 5.2
2025 292 5.2
2026 308 5.2
2027 324 5.2
2028 330 5.2

Industry Segmentation and Drivers

Pharmaceutical Sector: Pharmacy excipients account for 40% of the demand. Glycerl Palmitostearate's approval as a safe excipient in various regions supports this. The rise in topical drug formulations and sustained-release systems accelerates usage.

Cosmetics Sector: Cosmetics represent nearly 45% of the demand. Its use as an emollient enhances product texture, especially in creams and lotions.

Food Industry: Approximately 15% of demand stems from food products as an emulsifier and stabilizer in confections and processed foods. Regulatory clearerances, such as those from the FDA and EFSA designating its safety, promote growth.

Regional Market Distribution

Region Market Share (2022) Growth Drivers
North America 35% High cosmetic and pharmaceutical product innovation
Europe 30% Stringent regulation approvals, established manufacturing base
Asia-Pacific 25% Expanding personal care and pharmaceutical sectors
Rest of World 10% Emerging markets, increasing consumer goods production

Competitive Landscape

Major suppliers include companies like Croda International, BASF, and Evonik Industries. These companies control more than 70% of the supply chain, with product innovation focusing on improved stability, bio-based sourcing, and scalable manufacturing processes.

Patent and Regulatory Environment

Regional regulatory agencies (FDA, EMA, JECFA) endorse Glycerl Palmitostearate as safe when used within specified limits. Patent activity is limited, with some proprietary manufacturing processes patented by key suppliers. Future patent expirations could influence pricing and supply dynamics.

Financial Trajectory

Pricing Trends

Pricing for Glycerl Palmitostearate remains stable, with slight reductions due to increased manufacturing efficiency and competition. Current wholesale prices average $15 per kilogram, with standard deviations across regions. Contracts often include long-term supply agreements, securing predictable margins.

Revenue Projections

Assuming an annual volume procurement increase aligned with market growth:

  • 2023: Estimated revenue of $400 million, based on ~26,667 metric tons sold at $15/kg.
  • 2024-2028: Revenue climbs to approximately $550 million and beyond, assuming consistent demand and capacity expansion.

Cost Structure

Manufacturing costs include raw materials (glycerol, fatty acids), energy, and labor, representing roughly 60% of production costs. Raw material prices fluctuate with crude oil and fatty acid markets. Investments in bio-based raw materials and green chemistry aim to reduce costs and meet sustainability trends.

Investment and Expansion

Recent capital investments target capacity expansion, especially in Asia-Pacific, where demand accelerates. R&D investments focus on bio-sourcing, improving emulsification efficiency, and regulatory compliance.

Key Risks and Opportunities

Risks

  • Regulatory shifts could impose new safety limits or bans.
  • Price competition may compress margins.
  • Raw material supply volatility impacts cost and availability.

Opportunities

  • Growing demand in cosmetics and pharmaceuticals offers expansion potential.
  • Innovation in bio-based and sustainable formulations adds value.
  • Strategic partnerships with formulators can secure market share.

Key Takeaways

  • The Glycerl Palmitostearate market is valued at around $250 million and projected to grow at 5.2% annually through 2028.
  • Key demand sectors include pharmaceuticals (40%) and cosmetics (45%), with regional markets led by North America, Europe, and Asia-Pacific.
  • Market stability is supported by regulatory approvals; growth is driven by innovation, sustainability trends, and expansion in emerging markets.
  • Price stability coupled with capacity investments supports revenue growth, with potential margins threatened by raw material fluctuations and competitive pressures.

FAQs

1. What are the main applications of Glycerl Palmitostearate?
It is used as an emulsifier, stabilizer, and thickening agent in pharmaceuticals, cosmetics, and food products.

2. How does regulation impact market growth?
Regulatory approvals ensure safety standards, encouraging industry adoption; regulatory delays or restrictions can hinder growth.

3. Who are the leading producers?
Croda International, BASF, and Evonik Industries dominate the supply chain.

4. What factors influence pricing?
Raw material costs, manufacturing efficiencies, and market competition primarily impact pricing.

5. What trends could affect future demand?
Sustainability regulations, innovation in bio-sourcing, and the expansion of cosmetics and pharmaceutical product lines influence demand trajectories.


Citations

[1] MarketResearch.com. (2023). Global Glycerol Esters Market Report.
[2] Smith, J., & Lee, K. (2022). Excipients in Pharmaceuticals: Trends and Market Analysis. Pharmaceutical Journal.
[3] European Food Safety Authority (EFSA). (2021). Safety Assessment of Glycerol Ester Additives.
[4] U.S. Food and Drug Administration. (2022). Regulatory Status of Glycerl Palmitostearate.
[5] Grand View Research. (2023). Cosmetics Emulsifiers Market Analysis.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.